Connection
Andrew Morris to Proto-Oncogene Proteins c-akt
This is a "connection" page, showing publications Andrew Morris has written about Proto-Oncogene Proteins c-akt.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.057 |
|
|
|
-
Chadid T, Morris A, Surowiec A, Robinson S, Sasaki M, Galipeau J, Pollack BP, Brewster LP. Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients. J Vasc Surg. 2018 12; 68(6S):137S-151S.e2.
Score: 0.034
-
Xiang B, Zhang G, Ren H, Sunkara M, Morris AJ, Gartner TK, Smyth SS, Li Z. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism. PLoS One. 2012; 7(12):e51037.
Score: 0.023